Appletree Medical Group

appletreemedicalgroup.com

For almost 30 years, Appletree Medical Group has focused on improving community healthcare. Thanks to years of continuous innovation, we have grown to become one of the largest multidisciplinary community health groups in Canada, preferred by both patients and health professionals alike. Whether by visiting one of our 75 medical centres or telemedicine sites, or connecting through our Virtual Care app, Appletree patients are given greater control over their healthcare.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech

BIO-ISAC AND NEW YORK METRO INFRAGARD MEMBERSHIP ALLIANCE ANNOUNCE PARTNERSHIP

NY Metro InfraGard | April 28, 2022

news image

The Bioeconomy Information Sharing and Analysis Center (BIO-ISAC) and New York Metro InfraGard Members Alliance® (NYM-IMA) today announced a partnership to address threats unique to the bioeconomy and enable coordination among stakeholders to facilitate a robust and secure industry. BIO-ISAC is a critical resource for cyber threat detection, prevention, protection, response, recovery and resilience in the bioeconomy. It helps spur the development and evaluation of defensive to...

Read More

Research

INSTITUTE FOR BIOSCIENCE AND BIOTECHNOLOGY RESEARCH RECEIVES $16.8 M INVESTMENT FROM THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY

Institute for Bioscience and Biotechnology Research | January 14, 2022

news image

The Institute for Bioscience and Biotechnology Research announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments...

Read More

CAMENA BIOSCIENCE HITS DNA SYNTHESIS MILESTONE

Labiotech | February 06, 2020

news image

Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being placed on DNA sequencing and manipulation tools....

Read More

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

news image

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More
news image

MedTech

BIO-ISAC AND NEW YORK METRO INFRAGARD MEMBERSHIP ALLIANCE ANNOUNCE PARTNERSHIP

NY Metro InfraGard | April 28, 2022

The Bioeconomy Information Sharing and Analysis Center (BIO-ISAC) and New York Metro InfraGard Members Alliance® (NYM-IMA) today announced a partnership to address threats unique to the bioeconomy and enable coordination among stakeholders to facilitate a robust and secure industry. BIO-ISAC is a critical resource for cyber threat detection, prevention, protection, response, recovery and resilience in the bioeconomy. It helps spur the development and evaluation of defensive to...

Read More
news image

Research

INSTITUTE FOR BIOSCIENCE AND BIOTECHNOLOGY RESEARCH RECEIVES $16.8 M INVESTMENT FROM THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY

Institute for Bioscience and Biotechnology Research | January 14, 2022

The Institute for Bioscience and Biotechnology Research announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments...

Read More
news image

CAMENA BIOSCIENCE HITS DNA SYNTHESIS MILESTONE

Labiotech | February 06, 2020

Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being placed on DNA sequencing and manipulation tools....

Read More
news image

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us